Inconsistent condom use among HIV-positive women in the "Treatment as Prevention Era": data from the Italian DIDI study
- PMID: 24135086
- PMCID: PMC3798584
- DOI: 10.7448/IAS.16.1.18591
Inconsistent condom use among HIV-positive women in the "Treatment as Prevention Era": data from the Italian DIDI study
Abstract
Introduction: Translation of the evidence regarding the protective role of highly active antiretroviral therapy (HAART) on HIV sexual transmission rates into sexual behaviour patterns of HIV-infected subjects remains largely unexplored. This study aims to describe frequency of self-reported condom use among women living with HIV in Italy and to investigate the variables associated with inconsistent condom use (ICU).
Methods: DIDI (Donne con Infezione Da HIV) is an Italian multicentre study based on a questionnaire survey performed during November 2010 and February 2011. Women-reported frequency of condom use was dichotomized in "always" versus "at times"/"never" (ICU).
Results: Among 343 women, prevalence of ICU was 44.3%. Women declared a stable partnership with an HIV-negative (38%) and with an HIV-positive person (43%), or an occasional sexual partner (19%). Among the 194 women engaged in a stable HIV-negative or an occasional partnership, 51% reported fear of infecting the partner. Nonetheless, 43% did not disclose HIV-positive status. Less than 5% of women used contraceptive methods other than condoms. At multivariable analysis, variables associated with ICU in the subgroup of women with a stable HIV-negative or an occasional HIV-unknown partner were: having an occasional partner (AOR 3.51, 95% confidence interval [CI] 1.44-8.54, p=0.005), and reporting fear of infecting the sexual partner (AOR 3.20, 95% CI 1.43-7.16, p=0.004). Current use of HAART together with virological control in plasma level did not predict ICU after adjusting for demographic, behavioural and HIV-related factors. With regard to socio-demographic factors, lower education was the only variable significantly associated with ICU in the multivariate analysis (AOR 2.27, 95% CI 1.07-4.82, p=0.03). No association was found between high adherence to HAART and ICU after adjusting for potential confounders (AOR 0.89, 95% CI 0.39-2.01, p=0.78).
Conclusions: Currently in Italy, the use of HAART with undetectable HIV RNA in plasma as well as antiretroviral adherence is not associated with a specific condom use pattern in women living with HIV and engaged with a sero-discordant or an HIV-unknown partner. This might suggest that the awareness of the protective role of antiretroviral treatment on HIV sexual transmission is still limited among HIV-infected persons, at least in this country.
Keywords: HIV; adherence; antiviral therapy; condom use; women.
Figures
Similar articles
-
Consistent condom use among highly effective contraceptive users in an HIV-endemic area in rural Kenya.PLoS One. 2019 May 6;14(5):e0216208. doi: 10.1371/journal.pone.0216208. eCollection 2019. PLoS One. 2019. PMID: 31059524 Free PMC article.
-
Couple communication, sexual coercion and HIV risk reduction in Kigali, Rwanda.AIDS. 1995 Aug;9(8):935-44. doi: 10.1097/00002030-199508000-00016. AIDS. 1995. PMID: 7576330
-
Impact on sexually transmitted disease spread of increased condom use by young females, 1987-1992.Int J Epidemiol. 1995 Aug;24(4):813-20. doi: 10.1093/ije/24.4.813. Int J Epidemiol. 1995. PMID: 8550280
-
Patterns of condom use and sexual behavior among never-married women.Sex Transm Dis. 1993 Jul-Aug;20(4):201-8. doi: 10.1097/00007435-199307000-00005. Sex Transm Dis. 1993. PMID: 8211537
-
[Current status of the female condom in Africa].Sante. 1997 Nov-Dec;7(6):405-15. Sante. 1997. PMID: 9503499 Review. French.
Cited by
-
The Magnitude and Associated Factors of Consistent Condom Utilization Among ART Users in Hawassa City, Sidama, Ethiopia.HIV AIDS (Auckl). 2020 Dec 15;12:909-922. doi: 10.2147/HIV.S280143. eCollection 2020. HIV AIDS (Auckl). 2020. PMID: 33364850 Free PMC article.
-
Priming with a simplified intradermal HIV-1 DNA vaccine regimen followed by boosting with recombinant HIV-1 MVA vaccine is safe and immunogenic: a phase IIa randomized clinical trial.PLoS One. 2015 Apr 15;10(4):e0119629. doi: 10.1371/journal.pone.0119629. eCollection 2015. PLoS One. 2015. PMID: 25875843 Free PMC article. Clinical Trial.
-
Condom Use among HIV-Positive Postnatal Women in Primary Health Care Facilities in Tshwane Sub-District 1, Gauteng Province, South Africa.Int J Environ Res Public Health. 2023 Oct 2;20(19):6877. doi: 10.3390/ijerph20196877. Int J Environ Res Public Health. 2023. PMID: 37835147 Free PMC article.
-
Consistent condom utilization and associated factors among HIV positive clients attending ART clinic at Pawi general hospital, North West Ethiopia.PLoS One. 2021 Dec 21;16(12):e0261581. doi: 10.1371/journal.pone.0261581. eCollection 2021. PLoS One. 2021. PMID: 34932611 Free PMC article.
-
Prevalence and predictors of facing a legal obligation to disclose HIV serostatus to sexual partners among people living with HIV who inject drugs in a Canadian setting:a cross-sectional analysis.CMAJ Open. 2016 Apr 28;4(2):E169-76. doi: 10.9778/cmajo.20150106. eCollection 2016 Apr-Jun. CMAJ Open. 2016. PMID: 27398360 Free PMC article.
References
-
- Vernazza P, Hirschel B, Bernasconi E, Flepp M. Les personne séropositives ne souffrant d'aucune autre MST et suivant un traitement antirétroviral efficace ne transmettent pas le VIH par voie sexuelle. Bulletin des Médecins Suisses. 2008;89:1304–1305.
-
- Rojas Castro D, Fugon L, Bourgeois-Fisson E, Le Gall JM, Barbier F, Spire B. The “Swiss Statement”: who knows about it? How do they know? What are the effects on people living with HIV/AIDS? AIDS Care. 2012;24(8):1013–9. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical